Global Infectious Diseases in November 2022: Monthly Analysis-Reference-Cited by-同舟云学术

Global Infectious Diseases in November 2022: Monthly Analysis

Published:2022-12-28 Issue:1 Volume:2 Page:
ISSN:2737-7466
Container-title:Zoonoses
language:en
Short-container-title:Zoonoses

Author:

Zou Jiazhen¹,He Shiping¹,Yu Wenjin²,Li Guodan¹,Li Taihan¹,Xiang Qi¹,Liu Dongliang¹,Luo Yi¹,Sun Yinfu¹,He Minjing¹,Zhang Shuqiong¹,Su Qun³,Gu Dayong¹

Affiliation:

1. Department of Laboratory Medicine, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, China

2. Shenzhen Data Thinking Corporation, Shenzhen, China

3. School of Computer and Information Engineering, Xiamen University of Technology, Xiamen, Fujian, China

Abstract

Infectious diseases, such as COVID-19 and monkeypox, pose a severe threat to economic development in all countries, as well as to the health of people everywhere. The World Health Organization and National Health Council epidemiological websites were used herein as data sources. Shusi Tech’s Global Epidemic Information Monitoring System was used to analyze the data for infectious diseases, determine changes in global epidemics, determine the distribution and quantity of infectious disease cases from October 24, 2022 to November 23, 2022, and analyze their changing trends. Furthermore, the analysis of these data can be used to predict prevalence rates, and assess epidemic prevention and control measures.

Publisher

Compuscript, Ltd.

Link

https://scienceopen.com/document_file/9f489223-3c20-4928-981f-0601bc958fce/ScienceOpen/Zoonoses20221004.pdf

Reference7 articles.

1. Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic;F Rahimi;Int J Surg,2022

2. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear;I Torjesen;BMJ,2021

3. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa;R Viana;Nature,2022

4. The epidemiological features of the SARS-CoV-2 Omicron subvariant BA.5 and its evasion of the neutralizing activity of vaccination and prior infection;D Tian;Vaccines (Basel),2022

5. Monkeypox;O Mitjà;Lancet,2022